Management of Bradycardia in Patients Taking Letrozole and Zoladex

Initial Assessment

• The American College of Cardiology recommends evaluating for symptoms and signs of poor perfusion, including altered mental status, ischemic chest discomfort, acute heart failure, hypotension, or other signs of shock in patients with bradycardia 1
• Clinically significant bradycardia typically occurs at heart rates <50 bpm, and documentation of heart rate patterns with cardiac monitoring and a 12-lead ECG is necessary to identify rhythm and conduction abnormalities 1
• Assessment for hypoxemia, metabolic abnormalities, endocrine dysfunction, or infection is crucial in identifying reversible causes of bradycardia 1

Management Based on Symptom Severity

• The American College of Cardiology recommends no intervention for asymptomatic bradycardia, and continuation of monitoring with periodic ECGs and vital signs is sufficient 2
• For symptomatic bradycardia with hemodynamic compromise, immediate intervention is required, and atropine 1 mg IV may be administered, with repeat doses every 3-5 minutes up to 3 mg total 3, 4
• The American College of Cardiology suggests considering temporary transcutaneous pacing for severe symptoms until bradycardia resolves, and temporary transvenous pacing is reasonable for persistent hemodynamically unstable bradycardia refractory to medical therapy 4

Medication-Specific Considerations

• The American College of Cardiology guidelines for glucagon, high-dose insulin therapy, and IV calcium apply specifically to beta-blocker or calcium channel blocker overdose, and are not indicated for letrozole/goserelin-induced bradycardia 2, 3, 4

Monitoring and Follow-Up

• Serial ECGs and symptom assessment should be performed weekly initially, then monthly once stable, and measurement of serum electrolytes (potassium, magnesium, calcium) is necessary as abnormalities can exacerbate bradycardia 3, 5

Key Pitfalls to Avoid

• The American College of Cardiology recommends avoiding atropine, temporary pacing, or permanent pacemaker placement in patients without symptoms or hemodynamic compromise, as asymptomatic bradycardia may represent physiologic adaptation and does not require intervention 1